Top Japanese Pharmas Show Appetite For Emerging Market Expansion, Will Generics Follow?
This article was originally published in PharmAsia News
Executive Summary
TOKYO - Japanese pharma companies are trying to determine how to expand into new markets, ranging from the U.S. to China, and IMS Health data show a slow move away from dependence on the domestic market for Japan's leading companies
You may also be interested in...
EFPIA Hopes To Shift Conversation In Japan From Pricing To Funding
The European pharma trade group also plans communication offensive on health technology assessment as Japan reconsiders pricing methodology.
Alliances Up In Japan, And A Shift To Overseas Markets
Japanese pharma appetite for licensing deals exploded in 2011, as did appetite for foreign marketing rights.
Alliances Up In Japan, And A Shift To Overseas Markets
Japanese pharma’s appetite for licensing deals exploded in 2011, as did its appetite for foreign marketing rights.